However, in an in vivo mouse model of AD, the complete loss of CLU and its haploinsufficiency corresponded with a worsened condition of tau pathology and the substantial augmentation in amyloid load, respectively [66,67]. The gene discussed is MAPT; the disease is Alzheimer disease.